Abbott Laboratories
0
0
0%

Financials

Cash flow

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Operating activities 2.8B 2.0B 1.4B 10.2B
Net income 1.6B 1.8B 1.3B 9.2B
Depreciation 791M 777M 756M 807M
Deferred taxes
StockBased compensation 120M 142M 289M 111M
Other non cash items 221M -244M -436M
Accounts receivable -202M -410M -262M -158M
Accounts payable
Other assets liabilities 213M 3M -255M 235M
Investing activities -547M -500M -478M -716M
Capital expenditures -496M -502M -484M -720M
Net intangibles
Net acquisitions -55M 0
Purchase of investments
Sale of investments
Other investing activity 4M 2M 6M 4M
Financing activities -1.8B -1.1B -2.3B -1.9B
Long term debt issuance 0 2M 1M 1M
Long term debt payments -501M -1M -1.0B -640M
Short term debt issuance 8M -16M -36M 26M
Common stock issuance
Common stock repurchase -305M -6M -280M -315M
Common dividends -1.0B -1.0B -1.0B -958M
Other financing charges 0
End cash position 7.5B 7.0B 6.5B 7.6B
Income tax paid
Interest paid
Free cash flow 2.3B 1.5B 933M 2.1B
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 13 hours 32 minutes

19:57
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).